Clinical trial
Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes
NCT00184639 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184639 |
|---|---|
| Title | Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes |
| Official title | Comparison of Efficacy and Safety of Insulin Detemir and Insulin Semilente®MC in Children, Adolescents and Young Adults With Type 1 Diabetes on Basal-Bolus Regimen. |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin detemir |
| Enrollment | 71 |
| Start date | Aug 16, 2004 |
| Primary completion | Nov 22, 2005 |
| Completion | Nov 22, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 24, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: